Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Vancomycin on the Gut Microbiome and Immune Function in Multiple Sclerosis

NCT05539729 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT05539729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05539729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Vancomycin on the Gut Microbiome and Immune Function in Multiple Sclerosis
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 1
Overall status
Recruiting
Start date
January 31, 2023
Completion date
December 31, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis